Form 8-K - Current report:
SEC Accession No. 0001564590-20-053289
Filing Date
2020-11-12
Accepted
2020-11-12 07:31:20
Documents
15
Period of Report
2020-11-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K idxx-8k_20201111.htm   iXBRL 8-K 56921
2 EX-99.1 d18764dex991.htm EX-99.1 5629
3 GRAPHIC g18764logo.jpg GRAPHIC 14875
4 GRAPHIC gew4biifg13o000001.jpg GRAPHIC 2144
  Complete submission text file 0001564590-20-053289.txt   219363

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA idxx-20201111.xsd EX-101.SCH 5764
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE idxx-20201111_lab.xml EX-101.LAB 18708
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idxx-20201111_pre.xml EX-101.PRE 11164
8 EXTRACTED XBRL INSTANCE DOCUMENT idxx-8k_20201111_htm.xml XML 3420
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Filer) CIK: 0000874716 (see all company filings)

EIN.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19271 | Film No.: 201303376
SIC: 2835 In Vitro & In Vivo Diagnostic Substances